Indegene Lifesystems Pvt. Ltd., a leading provider of R&D, commercial and marketing solutions to top global pharmaceutical and healthcare organizations, has now entered into  a definitive agreement to acquire the multi-channel, video and e-detailing, and physician marketing services business of Aptilon Holdings Inc., a wholly owned subsidiary of Aptilon Corporation.

The Canada-based Aptilon  has  several large pharmaceutical, biotech and healthcare clients in the United States, Canada and Europe. Now Indegene will be able to access Aptilon’s clients and interact with over 500,000 physicians and healthcare professionals via multiple access channels including iPADs, mobile and desktop media. Its innovative service and platform offerings, including Live Central and Channel HQ, provide targeted impressions and interactions through “click-to-talk” video and mobile detailing, digital access ‘on-demand’ channels and permission-based email services that drive efficient physician recruitment and outcomes.

The need for intelligent, robust, and outcome-driven multi-channel marketing (MCM) and Virtual/Inside Sales programs is estimated to represent a US$ 10 billion opportunity as companies continue to accelerate the transformation of their sales and marketing organizations over the next 4-5 years.

 “By combining Indegene’s Virtual/Inside Sales and MCM capabilities with Aptilon's technology platforms, significant physician reach, and multi-year data on physician behaviour in the North American and European market, clients can accelerate their physician engagement strategies and deploy true end-to-end world-class programs,” said Manish Gupta, CEO, Indegene.

Denis Martineau, president, Aptilon Holdings Inc. said that through this proposed transaction, our clients will gain access to an accelerated approach to drive integrated physician engagement programmes. In addition, our clients can leverage global expertise and infrastructure assets in US, Europe and Emerging Markets to enhance productivity as well as effectiveness.”

Upon completion of the acquisition, Aptilon’s multi-channel, e-detailing, and physician marketing services businesses will be rolled under Indegene Aptilon, Inc.  which is  a wholly-owned subsidiary of Indegene Lifesystems Pvt. Ltd.

According to Dr. Rajesh Nair, president, Indegene, the acquisition presents us with a unique opportunity to further consolidate our Virtual/Inside sales offering. We expect the synergies of this acquisition to create around 200 new jobs in USA and Canada, and an additional 1,000 jobs in India and China as we ramp up to address this need. We expect to complete this transaction in the next few weeks subject to customary closing conditions including obtaining necessary approvals from regulatory authorities.”